(Q38204774)

31 August 2017

title

Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination (English)

1 reference

31 August 2017

2

Mark Jit

1 reference

31 August 2017

Emma Quinn

1

1 reference

31 August 2017

Anthony T Newall

series ordinal

3

1 reference

31 August 2017

language of work or name

1 reference

16 April 2014

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

31 August 2017

published in

1 reference

31 August 2017

volume

14

1 reference

31 August 2017

issue

3

1 reference

31 August 2017

page(s)

425-435

1 reference

Seasonal influenza: the burden of disease in children

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Burden of paediatric influenza in Western Europe: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Influenza and respiratory syncytial virus in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

The importance of influenza prevention for public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Vaccines for seasonal and pandemic influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Influenza vaccines: from surveillance through production to protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Evaluation of Southern Hemisphere influenza vaccine recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

The rationale for quadrivalent influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

The coming era of quadrivalent human influenza vaccines: who will benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Quadrivalent Ann Arbor strain live-attenuated influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

The need for quadrivalent vaccine against seasonal influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Genetic and phenotypic analysis of reassortants of high growth and low growth strains of influenza B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

The economic value of a quadrivalent versus trivalent influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Time-series analyses of count data to estimate the burden of seasonal infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Validation of statistical models for estimating hospitalization associated with influenza and other respiratory viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Development and validation of a risk score for predicting hospitalization in children with influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Mortality associated with influenza and respiratory syncytial virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Influenza-associated hospitalizations in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Estimates of US influenza-associated deaths made using four different methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Mortality due to influenza in the United States--an annualized regression approach using multiple-cause mortality data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Clinical manifestations and socio-economic impact of influenza among healthy children in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Global production capacity of seasonal influenza vaccine in 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

Assessing the burden of influenza and other respiratory infections in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

The burden of influenza B: a structured literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.2014.908713

10.1586/14737167.2014.908713

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference